Canadian Goverment grants CTI license to sell BCS2100 in Canada. No restrictions-i.e. is not limited to use as an adjunct to mammography. Same clinical data used in application as provided to FDA. The Canadian process spanned a 2+year effort.
Pharma, Biotech And Device Colloquium
June 6-9, 2004
Princeton University campus
Pharma, Biotech and Device Colloquium, June 6-9, 2004, on the campus of Princeton University, the major advanced executive education event covering the interface of regulation and business strategy for global pharmaceutical, biotechnology and medical device enterprises. Featuring a faculty of over eighty national experts, including Mark B. McClellan, MD, Ph.D., Administrator, Centers for Medicare & Medicaid Services, Washington; Fred Hassan, MBA, Chairman and Chief Executive Officer, Schering-Plough Corporation, Past Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA); P. Roy Vagelos, MD, Retired Chief Executive Officer and Chairman, Merck & Co.; Pat Kelly, President, US Pharmaceuticals, Vice President, Pfizer Inc.; John C. Lechleiter, Ph.D., Executive Vice President, Pharmaceutical Operations, Eli Lilly and Company; and Uwe E. Reinhardt, Ph.D., James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University. The Colloquium is sponsored by AdvaMed, Biotechnology Industry Association, Harvard Health Policy Review, Health Affairs, Healthcare Institute of New Jersey, National Pharmaceutical Council, Pharmaceutical Care Management Association and Pharmaceutical Compliance Forum. |
